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One of the features of both types of BL is the presence of a characteristic reciprocal chromosomal translocation involving chromosome 8 at the site of the c-myc proto-oncogene. The second chromosome involved is most commonly chromosome 14, with the breakpoint at 14q32, the site of the immunoglobulin heavy chain
The presumed effect of this reciprocal translocation is to bring the c-myc gene under the influence of the Ig enhancer, thereby activating transcription of the c-myc gene, and ultimately leading to proliferation of the B cell and subsequent malignancy. ' The nature of the cell of origin in endemic BL is unclear;
tations had not accumulated in vitro. In a further case, there was evidence of sequence heterogeneity, which appeared to have been generated in vivo, indicating that the tumor cell VH gene was able to undergo posttranslocation somatic hypermutation. Analysis of the relatively nonpolymorphic vH4 genes for the pattern of replacement or silent mutations did not show a role for antigen selection in the expressed sequences.
0 1995 b y The American Society of Hematology.
morphology and cell surface marker analysis have suggested a derivation from the germinal center,* and foci of tumor cells can be seen in germinal centers.' However, the site of tumor growth is often in the jaw or ovary, tissues that do not contain germinal centers under normal conditions.'" From an immunogenetic view, the fact that the translocation often involves the JH region of the immunoglobulin gene, has led to the suggestion that the translocation event occurs during the recombination of the VH-DH-JH elements at an early stage of B-cell development."'," Clearly, if this is the case, the cell harboring the translocation can differentiate further to the more mature Ig-expressing tumor cell characteristic of BL.
Studies on normal B-cell differentiation have indicated that somatic hypermutation of V-genes occurs in the germinal center." This process results in the introduction of point mutations in the variable, but not the constant regions of the gene sequences." If cells expressing the mutated sequences are then exposed to limiting antigen, this interaction will result in stimulation of only those cells that bind antigen most efficiently, thereby leading to selection of V-gene sequences encoding amino acids of best fit, with unstimulated cells undergoing apoptosis." Therefore, antigen-selected sequences tend to have a concentration of mutations leading to replacement amino acids in the complementarity-determining regions (CDRs).
In the case of B-cell tumors, which may be considered as normal B cells frozen at a point of differentiation by neoplastic transformation, the mutational patterns of the V-genes reflect the clonal history of the cell of origin.I4 For follicular lymphoma, the tumor cells often harbor significant mutations, some of which appear to have been influenced by antigen selection," indicating that the cell of origin has been exposed to the somatic hypermutation mechanism, and may have undergone antigen selection. In contrast, cells from chronic lymphocytic leukemia (CLL) are generally unmutated,I5 although there may be subsets of CLL, some of which are unusual in expressing IgG, which do harbor mutations." This analysis of VH genes, which adds another parameter to the classification of B-cell tumors, has now been extended to a distinct B-cell neoplasm, BL.
MATERIALS AND METHODS
Cell lines, The BL cell lines were established from tumor biopsies obtained from children with a histologic diagnosis of BL, and have been described.""" All were of African origin with the excep- 
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Fig 1 tion of W 1 from New Guinea. All the lines were positive for the EBV genome and had the t(8; 14) (q24;q32) translocation. For WWI, cells were harvested at passage 10 (early passage) and subsequently at passage 213 (late passage), and were stored frozen in liquid nitrogen. Lines MUTU I and 111 were from the same patient and represent cells, which were subcloned at passage 10, and then maintained separately for approximately 90 passages. The MUTU cell lines differed in appearance, with MUTU I growing as a carpet of small round cells, phenotypically close to the original biopsy, and MUTU I11 being more lymphoblastoid in morphology and phenotype.lR The MUTU I to 111 transition has been shown to be accompanied by altered expression of EBV latent proteins." The ELI cell line was established as a line without rigorous cloning, and an early and late passage separated by at least 50 passages were available.
Analysis of V, genes. For preparation of cDNA, total RNA was prepared from the tumor cell lines using RNAzol B (Biogenesis, Bournemouth, UK) and reverse transcribed using Moloney murine leukemia virus reverse transcriptase and an oligo dT primer (Pharmacia-LKB, Uppsala, Sweden). A total of 1/20 of a sample of cDNA was then amplified by polymerase chain reaction (PCR) using a mixture of oligonucleotide primers specific for each of the VH leader sequences of VH1 -6 families, together with an appropriate Cp or Cy constant region primer, using conditions as described." Amplified products were gel-purified, and either sequenced directly, or cloned by ligation into pGEM-T vector and transfected into JM109 competent bacteria (Promega, Madison, W). Nucleotide sequence analysis was by the dideoxy chain termination method, with alignment being made to EMBLKenBank and current databases (V-BASE sequence directory, Tomlinson et al, MRC Centre for Protein Engineering, Cambridge, UK) using MacVector 4.0 sequence analysis software (International Biotechnologies Inc, New Haven, CT). At least two independent PCR amplifications were performed from each sample.
RESULTS
V, gene usage by BL cell Lines. The deduced amino acid sequences of the six cell lines are shown in Fig 1, and nucleotide sequences have been submitted to the EMBL database (accession nos. 246269-46290). As indicated, 3 of 6 are derived from the VH4 family, with two of these from the V&-21 (V4.34) gene, and one from the rarely expressed DP70 gene; 2 of 6 are from vH3 and 1 of 6 from vH1. The sequences are compared with the closest germline genes available in the EMBL and current databases (see Methods), and in all cases show considerable deviation from the germline sequences (Fig 1 and Table 1 ). There are also mutations in the JH regions of all the lines. The degree of mutation appears high in both the IgM and IgG-positive lines ( Table  1) . Analysis of the CDR3 sequences showed usage of identifiable D-segment genes in some cases (Fig 2) , but homology was generally low, with evidence for complex use of more than one D-gene.
Occurrence of mutations in V, genes. The first point to be investigated is whether the extensive mutations observed in the cell lines could have arisen during growth in vitro. To approach this question, we had available early and late passages of the WWl-BL line, separated by >200 population doublings in vitro, and sublines of the MUTU-BL line, which had been maintained separately in culture for >l00 doublings. For WW 1 and MUTU, the deduced sequences of the independent lines were identical (Fig l) , and identity was seen even at the nucleotide level. This demonstrates that no mutations have occurred in vitro, and that the mutations seen in the lines are most likely to have occurred in vivo.
IntracLonal heterogeneity. For the WW1 and MUTU lines, and also for Namalwa, WAN and RAEL lines, 5 to 7 individual sequences from at least two separate PCR products demonstrated no nucleotide differences, indicating no intraclonal variation at the level of the VH genes. However, for the third cell line, ELI, which had not been formally cloned, this procedure showed that, although the majority of the mutations were present in all clones, there was some heterogeneity in the mutational pattern (Fig 3) . A similar heterogeneous pattern was seen in the ELI line at both early and late passage, with the majority of the mutations evident in clones from each passage (Fig 3) . This suggests that the heterogeneity is likely to have been present in the original biopsy and has persisted during culture. Mutational patterns in V, genes. The number of mutations in the VH sequences of the cell lines in comparison to the closest germline genes is large (Fig 1) . Because the VH germline repertoire has now been delineated,21.22 these are likely to be either somatic mutations or polymorphisms, although the latter would have to be unusually extensive to account for the number of changes. A confident analysis of mutational patterns in expressed polymorphic genes requires knowledge of the corresponding germline gene in the patient. Without access to that material, deviations from germline sequence must be considered as putative somatic mutations. The VH3 family is highly prone to polymorphic ~ariation,'~ which renders the assignment of the germline counterparts of the MUTU and RAEL sequences particularly difficult. In the case of RAEL, the near germline identity of the J&b region makes it likely that it is derived from an unknown or polymorphic VH3 gene segment.
Because of these considerations, mutational analysis of BL has been confined to the less polymorphic genes. The VH4-21 (V4.34) gene, which is used by two of the lines, has a very low level of polymorphic ~ariation.'~ In fact, there is only one nucleotide difference (position 15 in FWRl), between the germline sequences of the V&-21 gene reported originallyz5 and the more recent analysis." Interestingly, the BL lines W 1 and ELI differ from each other at this position (see accession numbers). Less is known of the DP70 gene, which is used by the Namalwa cell line, because there are few available sequences, but it is closely related to the V1 l gene, which has a low polymorphi~m.~~ Therefore, although the location of mutations in the CDR or FWR is indicated for all the cell lines (Table l) , detailed mutational analysis has been restricted to the three cases involving vH4. Table 2 compares the distribution of replacement and silent mutations observed to that expected by chance. In all three cases, the deviation from the distribution due to chance was not significant, indicating no concentration of replacement amino acids in CDRl and CDR2, which would be consistent with a conventional role for antigen in selection. However, there is increasing evidence for more unconventional binding of antigen to sequences outside the CDRs; an extreme example of this is the binding of the red blood cell Vi antigen to a 
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DISCUSSION
Analysis of the rearranged functional variable region genes in B-cell tumors is providing information, which relates to the clonal history of the cell of origin. In particular, the accumulation of somatic mutations in the V genes indicates that the cell has been exposed to the hypermutation mechanism, and has traversed the germinal center." Endemic BL is a widely studied B-cell tumor, largely due to the fact that a number of tumor cell lines have been successfully established in ~u1ture.l~ However, to deduce useful data on the degree or pattern of somatic mutation of V-genes in these tumors, it is necessary to consider if such mutations could have arisen in vitro; if this were to be the case, it would be difficult to extrapolate back to the cell of origin.
Studies of myeloma cell lines have indicated that somatic mutation of V-genes does not occur in vitro.28 However, an analysis of variant sublines of the BL cell line, Namalwa, showed dramatic changes in both Ig and c-myc genes visible by Southern blotting techniques,29 which were interpreted as reflecting mutational activity in vitro. Although it was claimed that clonal relatedness of the sublines was evident from DNA fingerprinting, it would be useful to examine the clonal signature of B cells, the CDR3 sequence, to confirm these unexpected findings. In contrast, our experience with EBV-transformed cell lines established from patients with IgM-secreting B-cell tumors or with infectious mononucleosis has indicated a high degree of stability in the V-gene sequences in vitro. 26 We have been able to investigate two BL lines for this point. In the case of the MUTU line, subclones I and 111 were both derived from the same original biopsy, but had been cultured independently for > 100 passages before analysis; the two subclones were also phenotypically distinct in that a broadening of EBV latent gene expression in the MUTU 111 subclone had produced a switch from the original BL-like to a more LCL-like cellular phenotype.'* Despite this, the VH gene sequences, which were highly somatically mutated, were identical, indicating that these mutations are likely to have occurred in vivo, and that even following a change in phenotype and in expression of EBV latent genes, which manifested in vitro, the VH genes were stable. Similar results were obtained for the WW1 cell line, with a stable VH sequence over at least 203 passages. Extensive somatic hypermutation was seen in all six cell lines from the endemic form of BL. Studies of other types of BL, which include a single case of BL-like B-acute lymphoblastic leukemia (ALL),3o and two cases of post-acquired immune deficiency syndrome (AIDS) EBV-negative BL,31 have also shown extensive somatic mutations in VH genes, although in the ALL case, it was not possible to find a corresponding germline VH gene. Therefore, it appears that the tumor cell in both types of BL has been exposed to the hypermutation mechanism, and it is likely that this has occurred in the germinal center. In fact, in one of the endemic BL lines (ELI), which had not been rigorously cloned in vitro, there was clonal heterogeneity consistent with ongoing mutations occurring in vivo postneoplastic transformation. This pattern has also been observed in cases of follicular lymphoma (FL) , which generally carry a t(14; 18) (q32;q21) transl~cation,'~.~~ and suggests that the translocations in each of these classes of B-cell tumors do not preclude the cell from continuing to respond to the normal process of somatic hypermutation. The point of B-cell differentiation at which the translocation occurs is not known, although it seems logical to assume that, because the t(8; 14) translocation in the endemic form of BL generally involves the JH region, it is during V-D-J joining."." However, in that case, the translocated cell is able to undergo somatic hypermutation and isotype switching, presumably in the germinal center. One unexpected finding is that the ELI tumor, which expresses IgM and IgD, has apparently undergone extensive somatic hypermutation. Normal B cells, which express these isotypes, are generally considered to represent newly arisen cells with minimal somatic mutations,33 and recent findings with tonsillar B cells indicate that loss of surface IgD is associated with enhanced somatic mutation. 34 Whether the mutated VH genes are stimulated by antigen is unclear. Certainly in some cases of F L , the concentration of replacement mutations in the CDRs does suggest a role for antigen, and this is seen also in one of two documented cases of EBV-negative post-AIDS BL.3' Our sequences do not have this feature, and so the capacity to bind cognate antigen via CDRl and CDR2 may not be a selective force in BL pathogenesis. However, recognition of antigen also involves the CDR3 and perhaps FWR sequence^,^'.'^ leaving open a possible role for antigen. Clearly, more sequences of the V-genes of these tumors are required before this point is resolved. A further possibility is that aspects of the malignant phenotype of BL cells, in particular, the constitutive activation of c-rnyc expression '6 driving cell proliferation, may overcome the need for an antigen-mediated signal to ensure survival.
Besides emphasizing the similarity between the Burkitt tumor and normal germinal center cells, the fact that BL cells harbor hypermutated VH sequences is also potentially interesting in the wider context of BL pathogenesis. There is increasing recognition of the fact that the t(8; 14) translocation event is insufficient per se to achieve constitutive activation of c-myc function. Thus, detailed studies of the translocated c-rnyc allele have found consistent evidence of mutation from germline sequence, even in the context of endemic BL where the chromosome 8 breakpoint is some distance (up to several hundred kb) upstream of c-myc and where the triple exon structure of the gene remains essentially intact. These mutations affect both the regulatory first exon," where they may play a role in the promoter switching and release from transcriptional pausing, which typifies crnyc expression in BL cells,38 and also in the protein-coding sequence of the gene, affecting particularly the transactivation domain that is crucial for c-rnyc f~n c t i o n .~"~~ A unifying feature of the translocations in BL is the aberrant position of a c-myc allele upstream of an immunoglobulin constant region locus, ie, in a region usually occupied by V-region sequence. One interesting possibility is that, when a translocation-positive cell reaches the germinal center, the translocated c-myc gene becomes susceptible to the hypermutation mechanism, and it is here that the genetic changes resulting in constitutive c-myc activation are completed. This might help to explain why chronic infection with either Plasmodium falciparurn or with HIV, both organisms that can induce dramatic exaggeration of germinal center predisposes to BL development.
Burkitt's lymphoma has provided a paradigm for the way in which translocated protooncogenes can influence B-cell behavior and tumorigenesis.' Analysis of the VH genes of the tumor cells adds another piece of information to this and places BL among those tumors where the cell has encountered the mutator and has continued to be influenced by it, even after neoplastic transformation.
